Lung Health Analyses
A Systems Framework for Phenotyping and Precision Intervention
Lung health analysis is an international forum comprising reviews and monthly newsletters dedicated to understanding how biological, environmental and social factors modify the susceptibility, expression, progression and treatment response of lung disease. Our mission is to accelerate discovery and translation by delineating which modifiers matter, how they operate, and how they can be used to prevent disease, improve classification, enhance prognostication, and optimise therapy.
Priority areas include:
- Sex- and gender-specific lung health
- Pulmonary vascular biology and pulmonary circulation disorders
- Respiratory microbiome and metabolome
- Post-infectious and post-acute sequelae, including long-COVID
- Exposome, occupational and environmental determinants
- Neuro-immune and autonomic modifiers (e.g. dysautonomia)
- Systems and precision respiratory medicine
- Biomarker development, treatable traits and patient stratification
- Interactions between lung and other organ systems (heart–lung axis, gut–lung axis, neuro–lung axis)
Coming up:
What is the clinical and prognostic significance of CSA in cardiovascular populations, and should it be actively treated?
Who this report is for:
This report is intended for cardiologists, healthcare professionals, and researchers involved in cardiovascular medicine. It may also be relevant for medical educators and policymakers interested in treatment guidelines and prognostic assessments related to central sleep apnea (CSA) in patients with cardiovascular conditions.
A paraître:
Quelle est la signification clinique et pronostique de l’ACS dans les populations cardiovasculaires, et doit-elle être traitée activement ?
À qui s’adresse ce rapport :
Ce rapport est destiné aux cardiologues, aux professionnels de la santé et aux chercheurs impliqués dans la médecine cardiovasculaire. Il peut également être pertinent pour les éducateurs médicaux et les décideurs politiques intéressés par les directives de traitement et les évaluations pronostiques liées à l’apnée centrale du sommeil (ACS) chez les patients atteints de maladies cardiovasculaires.
Rejoignez-nous sur Substack pour des analyses et synthèses de recherche
Proximamente:
¿Cuál es el significado clínico y pronóstico de la ACS en las poblaciones cardiovasculares, y debería tratarse activamente?
Para quién es este informe:
Este informe está dirigido a cardiólogos, profesionales de la salud e investigadores involucrados en la medicina cardiovascular. También puede ser relevante para educadores médicos y responsables políticos interesados en las guías de tratamiento y evaluaciones pronósticas relacionadas con la apnea central del sueño (ACS) en pacientes con afecciones cardiovasculares.
Únase a nosotros en Substack para análisis y síntesis de investigación